Ocumetics Announces Completion of First Tranche of Debenture Private Placement for Net Proceeds of CA$2.82 Million
Life Science Investing Ocumetics Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcoming First in Human Study
Life Science Investing Ocumetics Welcomes Dr. Doyle Stulting and Dr. Bart McRoberts to Board of Directors
Life Science Investing Ocumetics Announces Commencement of Biocompatibility and Animal Studies for Updated Lens Design
